Charles River Labs has a strong history in supporting neuroscience and neurodegenerative diseases across all stages of drug ...

In a groundbreaking experiment, researchers have brought a mouse to life with the help of a single-celled organism that ...

Hiranmoy Das, Ph.D., a professor of pharmaceutical sciences at the Texas Tech University Health Sciences Center (TTUHSC) Jerry H. Hodge School of Pharmacy, has been named a Fellow of the National ...

Transplant is beneficial earlier in life, Wang told MedPage Today, but carries potential short- and long-term side effects.

On September 27, 2024, the U.S. Court of Appeals for the Ninth Circuit reversed the district court’s decision in U.S. v. California Stem ...

First Patient to Reach 6-Month Follow-up Remains in DORIS Clinical Remission and Free of All Immunosuppressive Therapies SAN DIEGO, Dec. 09, 2024 (GLOBE NEWSWIRE) -- Fate Therapeutics, Inc. (NASDAQ: ...

Arun Menawat, CEO of Profound Medical, talks about the company’s innovative TULSA-PRO technology. | Profound Medical CEO Arun ...

A groundbreaking study has used patient-derived stem cells to recreate a rare genetic form of autism in the lab.

Based on these observations Molecular Partners is amending the protocol of this study to further optimize the dosing schedule and improve the exposure profile of MP0533 in subsequent dosing cohorts.

Researchers at USC have discovered that the formation of new brain cells in adults, known as neurogenesis, is essential for ...

It was her freshman year when biomedical sciences senior Claudia Garrett heard Mark Vassar, a finance senior and president of ...

PhD Defense: Clinical Translational Aspects in Regeneration; From Bench to Bone ...